Primary sources first
We begin with FDA, Health Canada, Federal Register, state regulators, trial registries, official sponsor records, and original research. Commentary can add context but does not replace the underlying record.
Editorial standard · Updated August 22, 2026
Trust the method—or audit the source trail.
Peptide Evidence Watch is published under an organizational editorial desk. We do not use a fictional expert persona, imply medical review that did not occur, or ask readers to trust an anonymous claim without its evidence trail.
Authorship
Who creates the work.
Articles and briefs are attributed to the Peptide Evidence Watch Editorial Desk. Research and production use structured automation and AI assistance to monitor records, compare versions, organize sources, and support drafting. Publication remains governed by the standards on this page: source verification, evidence classification, limitations, medical and legal-claims review, structural editing, and a natural-language pass.
An organizational byline does not represent a medical credential. When a licensed clinician, pharmacist, scientist, or lawyer reviews a page, that person will be named with credentials, the scope of review, and the review date. Until that happens, the page will not say “medically reviewed” or “legally reviewed.”
Publication standard
Six rules every page must survive.
A page is not published merely because a topic is popular or a calendar says it is due.
Evidence lanes stay separate
Human clinical, animal, laboratory, regulatory, and anecdotal evidence are labeled separately. A mechanism, animal result, or recruiting trial is not presented as proof of benefit in people.
Status words retain their meaning
Proposal, staff recommendation, advisory vote, approval, compounding eligibility, enforcement allegation, and final agency action are not interchangeable.
Uncertainty is part of the answer
Material limitations and a credible competing interpretation are included. We do not turn an absence of evidence into proof of safety or harm.
Updates require a real change
Dates change only when the substance changes. Material source developments trigger review; cosmetic edits do not create fake freshness.
Corrections remain accountable
Potential errors are checked against the source record. Material corrections identify what changed, when it changed, and why.
Scope and independence
What this site will not do.
Peptide Evidence Watch provides education and market or regulatory intelligence. It does not diagnose, prescribe, recommend treatment, provide dosing or protocol guidance, rank gray-market suppliers, or sell peptides.
Commercial relationships will be disclosed where they could affect a reader’s interpretation. Compensated provider referrals are disabled unless providers are verified, written terms and legal review are complete, and the consumer gives explicit informed consent for the named recipient.
Corrections
Challenge a claim at the source.
Send the page URL, disputed sentence, and strongest supporting source to hello@peptideevidencewatch.com. The inbox is being activated; until it is live, no response-time promise is made. Material corrections will be dated and explained on the affected page.